Target Validation Information
TTD ID	T67079
Target Name	Interleukin-9 (IL9)
Type of Target	Clinical trial
Action against Disease Model	MEDI-528	Drug Info	As an IL-9 antagonist, MEDI-528 appears to inhibit a range of asthma pathogenic features in antigen-exposed mice.	[1]
References
REF 1	MEDI-528, an anti-IL-9 humanized antibody for the treatment of asthma. Curr Opin Mol Ther. 2010 Apr;12(2):233-9.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.